Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prior treatment with the tyrosine kinase inhibitors dasatinib and nilotinib allows stem cell transplantation (SCT) in a less advanced disease phase and does not increase SCT Toxicity in patients with chronic myelogenous leukemia and philadelphia positive acute lymphoblastic leukemia.

× No keyword cloud information.

13 in total

Review 1. Philadelphia-positive acute lymphoblastic leukemia: current treatment options.

Authors: Theresa Liu-Dumlao; Hagop Kantarjian; Deborah A Thomas; Susan O'Brien; Farhad Ravandi
Journal: Curr Oncol Rep Date: 2012-10 Impact factor: 5.075

Review 2. Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.

Authors: Nitin Jain; Koen van Besien
Journal: Hematol Oncol Clin North Am Date: 2011-10 Impact factor: 3.722

3. Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors: Naval Daver; Deborah Thomas; Farhad Ravandi; Jorge Cortes; Rebecca Garris; Elias Jabbour; Guillermo Garcia-Manero; Gautam Borthakur; Tapan Kadia; Michael Rytting; Marina Konopleva; Hagop Kantarjian; Susan O'Brien
Journal: Haematologica Date: 2015-02-14 Impact factor: 9.941

4. NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemia.

Authors: Susan O'Brien; Ellin Berman; Joseph O Moore; Javier Pinilla-Ibarz; Jerald P Radich; Paul J Shami; B Douglas Smith; David S Snyder; Hema M Sundar; Moshe Talpaz; Meir Wetzler
Journal: J Natl Compr Canc Netw Date: 2011-02 Impact factor: 11.908

5. Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after the first transplantation.

Authors: Yoko Ishida; Kiriko Terasako; Kumi Oshima; Kana Sakamoto; Masahiro Ashizawa; Miki Sato; Misato Kikuchi; Shun-Ichi Kimura; Hideki Nakasone; Shinya Okuda; Shinichi Kako; Rie Yamazaki; Junji Nishida; Yoshinobu Kanda
Journal: Int J Hematol Date: 2010-09-08 Impact factor: 2.490

Review 6. Allogeneic transplantation for CML in the TKI era: striking the right balance.

Authors: Andrew J Innes; Dragana Milojkovic; Jane F Apperley
Journal: Nat Rev Clin Oncol Date: 2015-11-17 Impact factor: 66.675

7. Successful prior treatment with dasatinib followed by stem cell transplantation in a patient with CML in blastic crisis with a BCR-ABL mutation.

Authors: Moritaka Gotoh; Tetsuzo Tauchi; Seiichiro Yoshizawa; Toshihiko Kitahara; Toru Kiguchi; Yukihiko Kimura; Kazuma Ohyashiki
Journal: Int J Hematol Date: 2010-01-05 Impact factor: 2.490

Review 8. Diagnostic and treatment of adult Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors: Xavier Thomas; Maël Heiblig
Journal: Int J Hematol Oncol Date: 2016-09-23

Review 9. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.

Authors: Michele Baccarani; Jorge Cortes; Fabrizio Pane; Dietger Niederwieser; Giuseppe Saglio; Jane Apperley; Francisco Cervantes; Michael Deininger; Alois Gratwohl; François Guilhot; Andreas Hochhaus; Mary Horowitz; Timothy Hughes; Hagop Kantarjian; Richard Larson; Jerald Radich; Bengt Simonsson; Richard T Silver; John Goldman; Rudiger Hehlmann
Journal: J Clin Oncol Date: 2009-11-02 Impact factor: 44.544

Review 10. Managing Philadelphia chromosome-positive acute lymphoblastic leukemia: role of tyrosine kinase inhibitors.

Authors: Farhad Ravandi
Journal: Clin Lymphoma Myeloma Leuk Date: 2011-04-08